202 related articles for article (PubMed ID: 18627423)
1. The natural compound atraric acid is an antagonist of the human androgen receptor inhibiting cellular invasiveness and prostate cancer cell growth.
Papaioannou M; Schleich S; Prade I; Degen S; Roell D; Schubert U; Tanner T; Claessens F; Matusch R; Baniahmad A
J Cell Mol Med; 2009 Aug; 13(8B):2210-2223. PubMed ID: 18627423
[TBL] [Abstract][Full Text] [Related]
2. NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growth.
Papaioannou M; Schleich S; Roell D; Schubert U; Tanner T; Claessens F; Matusch R; Baniahmad A
Invest New Drugs; 2010 Dec; 28(6):729-43. PubMed ID: 19771394
[TBL] [Abstract][Full Text] [Related]
3. The natural compounds atraric acid and N-butylbenzene-sulfonamide as antagonists of the human androgen receptor and inhibitors of prostate cancer cell growth.
Roell D; Baniahmad A
Mol Cell Endocrinol; 2011 Jan; 332(1-2):1-8. PubMed ID: 20965230
[TBL] [Abstract][Full Text] [Related]
4. A natural androgen receptor antagonist induces cellular senescence in prostate cancer cells.
Hessenkemper W; Roediger J; Bartsch S; Houtsmuller AB; van Royen ME; Petersen I; Grimm MO; Baniahmad A
Mol Endocrinol; 2014 Nov; 28(11):1831-40. PubMed ID: 25203674
[TBL] [Abstract][Full Text] [Related]
5. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
[TBL] [Abstract][Full Text] [Related]
6. Activity-guided isolation of an antiandrogenic compound of Pygeum africanum.
Schleich S; Papaioannou M; Baniahmad A; Matusch R
Planta Med; 2006 May; 72(6):547-51. PubMed ID: 16773539
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
8. Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.
Culig Z; Hoffmann J; Erdel M; Eder IE; Hobisch A; Hittmair A; Bartsch G; Utermann G; Schneider MR; Parczyk K; Klocker H
Br J Cancer; 1999 Sep; 81(2):242-51. PubMed ID: 10496349
[TBL] [Abstract][Full Text] [Related]
9. The natural compound atraric acid suppresses androgen-regulated neo-angiogenesis of castration-resistant prostate cancer through angiopoietin 2.
Ehsani M; Bartsch S; Rasa SMM; Dittmann J; Pungsrinont T; Neubert L; Huettner SS; Kotolloshi R; Schindler K; Ahmad A; Mosig AS; Adam L; Ori A; Neri F; Berndt A; Grimm MO; Baniahmad A
Oncogene; 2022 Jun; 41(23):3263-3277. PubMed ID: 35513564
[TBL] [Abstract][Full Text] [Related]
10. Computational and functional analysis of the androgen receptor antagonist atraric acid and its derivatives.
Papaioannou M; Söderholm AA; Hong W; Dai Y; Roediger J; Roell D; Thiele M; Nyrönen TH; Baniahmad A
Anticancer Agents Med Chem; 2013 Jun; 13(5):801-10. PubMed ID: 23194423
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antiproliferative and proapoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP-dependent protein kinase A.
Desiniotis A; Schäfer G; Klocker H; Eder IE
Int J Cancer; 2010 Feb; 126(3):775-89. PubMed ID: 19653278
[TBL] [Abstract][Full Text] [Related]
13. The adrenal androgen androstenediol is present in prostate cancer tissue after androgen deprivation therapy and activates mutated androgen receptor.
Mizokami A; Koh E; Fujita H; Maeda Y; Egawa M; Koshida K; Honma S; Keller ET; Namiki M
Cancer Res; 2004 Jan; 64(2):765-71. PubMed ID: 14744796
[TBL] [Abstract][Full Text] [Related]
14. Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cells.
Dehm SM; Tindall DJ
J Biol Chem; 2006 Sep; 281(38):27882-93. PubMed ID: 16870607
[TBL] [Abstract][Full Text] [Related]
15. Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells.
Schmidt A; Meissner RS; Gentile MA; Chisamore MJ; Opas EE; Scafonas A; Cusick TE; Gambone C; Pennypacker B; Hodor P; Perkins JJ; Bai C; Ferraro D; Bettoun DJ; Wilkinson HA; Alves SE; Flores O; Ray WJ
J Steroid Biochem Mol Biol; 2014 Sep; 143():29-39. PubMed ID: 24565564
[TBL] [Abstract][Full Text] [Related]
16. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
[TBL] [Abstract][Full Text] [Related]
17. A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells.
Wang Y; Kreisberg JI; Bedolla RG; Mikhailova M; deVere White RW; Ghosh PM
Oncogene; 2007 Sep; 26(41):6061-70. PubMed ID: 17420725
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models.
Zhang ZB; Ip SP; Cho WC; Hu Z; Huang YF; Luo DD; Xian YF; Lin ZX
J Ethnopharmacol; 2020 Oct; 260():113058. PubMed ID: 32525068
[TBL] [Abstract][Full Text] [Related]
19. Neoisoliquiritin exerts tumor suppressive effects on prostate cancer by repressing androgen receptor activity.
Chen C; Shao R; Li B; Zhai Y; Wang T; Li X; Miao L; Huang J; Liu R; Liu E; Zhu Y; Gao X; Zhang H; Wang Y
Phytomedicine; 2021 May; 85():153514. PubMed ID: 33676083
[TBL] [Abstract][Full Text] [Related]
20. The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cells.
Xu D; Lin TH; Zhang C; Tsai YC; Li S; Zhang J; Yin M; Yeh S; Chang C
Prostate; 2012 May; 72(7):803-16. PubMed ID: 21932429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
